Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “enterovirus”

5 pharma patents match "enterovirus" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "enterovirus" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “enterovirus” · 30,257 patents in full index Clear search

  1. US 11834451

    Compositions and methods for inhibiting virus protein 2C activity and for preventing and treating non-polio enterovirus infection

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted

  2. US 10555997

    Antigens and vaccines directed against human enteroviruses

    SENTINEXT THERAPEUTICS Sdn Bhd · Granted Feb 11, 2020 · Expires Feb 6, 2040

    granted

  3. US 10548964

    Antigens and vaccines directed against human enteroviruses

    SENTINEXT THERAPEUTICS Sdn Bhd · Granted Feb 4, 2020 · Expires Jan 30, 2040

    granted

  4. US 9987350

    Antigens and vaccines directed against human enteroviruses

    SENTINEXT THERAPEUTICS Sdn Bhd · Granted Jun 5, 2018 · Expires May 31, 2038

    granted

  5. US 8524676

    Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds

    Sarepta Therapeutics, Inc. · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.